Interview I Prof. Nikolaus Rajewsky I Einstein Center for Early Disease Interception: Cell-based precision medicine from Berlin

36 trillion cells, 400 cell types, 60 different tissues and organs: The sheer volume and complexity explain why changes are often not detected at the onset of a disease, but only when the first symptoms become apparent.

 

This is where the Einstein…

3 Min
More

Interview | Prof. Alexander Meyer, Director of the Institut für Künstliche Intelligenz in der Medizin (IKIM)

IKIM: A hub for AI in medicine

8 Min
More

Interview | Leonie Mentrup, Director Hospital, Doctolib Deutschland

“Lusatia has the potential to be a pioneer by national standards. The principles are transferable: Networking, administrative relief and patient-centered care work everywhere.”

5 Min
More

Interview | The Einstein Center Digital Future | Shaping and reflecting on digital transformation

The Einstein Center Digital Future, known as the ECDF, is a Berlin-based centre for digitalisation research. It stands for independent, interdisciplinary research into the shaping and critical reflection of digital transformation, developed in…

1 Min
More

Interview | Prof. Surjo Soekadar | Head of the research division Translation and Neurotechnology at Charité – Universitätsmedizin Berlin

NeuroTech Open Innovation Hub – Accelerating the Translation to Application for NeuroTech Innovation

6 Min
More
[Translate to English:]

Interview | Aleksandar Ivanovski | “Whether AI will change healthcare is no longer up for debate.”

Aleksandar Ivanovski is a senior machine learning engineer at Recare, a Berlin-based company that has been developing digital discharge management for hospitals since 2017 and now connects more than 700 acute care clinics.

1 Min
More

Interview | Dr. Sievert Weiss | “AI should not remain a magical ‘black box’, but should enrich healthcare.”

Dr. Sievert Weiss is a physician, co-founder, and medical director of AMBOSS. Since its founding, he and an interdisciplinary team have pursued the goal of making medical knowledge available where it is needed in everyday clinical practice.

1 Min
More

Interview | Aurélien Claeyssen, Managing Director, JPT Peptide Technologies GmbH | At Home in the House of Peptides

For more than 20 years, JPT Peptide Technologies has been producing peptides for scientific purposes and the pharmaceutical industry in Berlin. In the year 2009, the biotech company was acquired by Mainz-based BioNTech SE and has since grown…

6 Min
More

Interview | Dr. Jordi Casanellas, Director of AI at Bayer Pharma | Artificial Intelligence in Berlin

“Berlin's vibrant healthtech and AI ecosystem is a crucial component of Bayer's success”

1 Min
More

Interview | Dr. Harald Hasselmann, Chairman of the Executive Board of Eckert & Ziegler SE

Global and innovative – isotope technology components for precision oncology

4 Min
More
Show more items